Neuropathology and omics in motor neuron diseases

Neuropathology

Volumn 32, Issue 4, 2012, Pages 458-462

  Tanaka, Fumiaki ^a   Ikenaka, Kensuke ^a   Yamamoto, Masahiko ^b   Sobue, Gen ^a,c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ALS; CDNA microarray; Disease model; Dynactin 1; Omics

Indexed keywords

CASPASE 3; CASPASE 9; CELLULAR RETINOL BINDING PROTEIN 1; CHOLECYSTOKININ A RECEPTOR; CILIARY NEUROTROPHIC FACTOR; CYCLIN A1; CYCLIN C; DEATH RECEPTOR 5; DYNACTIN; DYNACTIN 1; DYNEIN ADENOSINE TRIPHOSPHATASE; EPHRIN A1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN ALPHA E PRECURSOR; INTERLEUKIN 1BETA CONVERTING ENZYME; METABOTROPIC RECEPTOR 6; MOLECULAR MOTOR; PRESENILIN 1; PROTEIN BAK; RETINOIC ACID RECEPTOR ALPHA; SCATTER FACTOR; SIGNAL RECOGNITION PARTICLE 14KD; SYNTAXIN 1B; TAU PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DNA MICROARRAY; DOWN REGULATION; DYNACTIN 1 GENE; GENE; GENE EXPRESSION REGULATION; GENOMICS; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; SPINAL CORD MOTONEURON; SPINAL CORD VENTRAL HORN; TRANSCRIPTOMICS; UPREGULATION;

ANIMALS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MOTOR NEURON DISEASE; PROTEOMICS;

EID: 84864132492     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01281.x     Document Type: Article

References (39)

1. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723-749.
2. Deng HX, Hentati A, Tainer JA etal. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993; 261: 1047-1051.
3. Rosen DR, Siddique T, Patterson D etal. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
4. Kabashi E, Valdmanis PN, Dion P etal. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008; 40: 572-574.
5. Sreedharan J, Blair IP, Tripathi VB etal. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668-1672.
6. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL etal. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-1208.
7. Vance C, Rogelj B, Hortobágyi T etal. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-1211.
8. de Carvalho M, Swash M. Amyotrophic lateral sclerosis: an update. Curr Opin Neurol 2011; 24: 497-503.
9. Maruyama H, Morino H, Ito H etal. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223-226.
10. Deng HX, Chen W, Hong ST etal. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011; 477: 211-215.
11. Dejesus-Hernandez M, Mackenzie IR, Boeve BF etal. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 2011; 72: 245-256.
12. Renton AE, Majounie E, Waite A etal. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 2011; 72: 257-268.
13. Gurney ME, Pu H, Chiu AY etal. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775.
14. Siciliano G, Carlesi C, Pasquali L etal. Clinical trials for neuroprotection in ALS. CNS Neurol Disord Drug Targets 2010; 9: 305-313.
15. Hideyama T, Yamashita T, Suzuki T etal. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci 2010; 30: 11917-11925.
16. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004; 427: 801.
17. Neumann M, Sampathu DM, Kwong LK etal. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
18. Arai T, Hasegawa M, Akiyama H etal. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
19. Malaspina A, de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Brain Res Rev 2004; 45: 213-229.
20. Jiang YM, Yamamoto M, Kobayashi Y etal. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 2005; 57: 236-251.
21. Tanaka F, Niwa J, Ishigaki S etal. Gene expression profiling toward understanding of ALS pathogenesis. Ann NY Acad Sci 2006; 1086: 1-10.
22. Jiang YM, Yamamoto M, Tanaka F etal. Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2007; 66: 617-627.
23. Schroer TA. Dynactin. Annu Rev Cell Dev Biol 2004; 20: 759-779.
24. Eschbach J, Dupuis L. Cytoplasmic dynein in neurodegeneration. Pharmacol Ther 2011; 130: 348-363.
25. Puls I, Jonnakuty C, LaMonte BH etal. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455-456.
26. Puls I, Oh SJ, Sumner CJ etal. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol 2005; 57: 687-694.
27. Williamson TL, Bruijn LI, Zhu Q etal. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci U S A 1998; 95: 9631-9636.
28. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004; 10: S10-S17.
29. Rothstein JD. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 19951996; 3: 348-359.
30. Wiedau-Pazos M, Goto JJ, Rabizadeh S etal. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518.
31. Duffy LM, Chapman AL, Shaw PJ, Grierson AJ. The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2011; 37: 336-352.
32. Guégan C, Vila M, Rosoklija G, Hays AP, Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 2001; 21: 6569-6576.
33. De Vos KJ, Grierson AJ, Ackerley S, Miller CC. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 2008; 31: 151-173.
34. Lai C, Lin X, Chandran J, Shim H, Yang WJ, Cai H. The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J Neurosci 2007; 27: 13982-13990.
35. Laird FM, Farah MH, Ackerley S etal. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J Neurosci 2008; 28: 1997-2005.
36. Chevalier-Larsen ES, Wallace KE, Pennise CR, Holzbaur EL. Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin. Hum Mol Genet 2008; 17: 1946-1955.
37. Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 1996; 47: 535-540.
38. Florez-McClure ML, Linseman DA, Chu CT etal. The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. J Neurosci 2004; 24: 4498-4509.
39. Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2011; 70: 349-359.